MedPath

裕松源药业有限公司

Ownership
-
Established
2003-08-28
Employees
-
Market Cap
-
Website
http://www.ysypharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

103

NMPA:103

Drug Approvals

Haloperidol Injection

Product Name
氟哌啶醇注射液
Approval Number
国药准字H20254394
Approval Date
May 27, 2025
NMPA

Betamethasone Sodium Phosphate Injection

Product Name
倍他米松磷酸钠注射液
Approval Number
国药准字H20253583
Approval Date
Mar 11, 2025
NMPA

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H20253395
Approval Date
Feb 20, 2025
NMPA

Aminophylline Injection

Product Name
氨茶碱注射液
Approval Number
国药准字H20247292
Approval Date
Nov 26, 2024
NMPA

鱼腥草注射液

Approval Number
国药准字Z41022315
Approval Date
Aug 19, 2021
NMPA

Glucurolactone Tablets

Product Name
葡醛内酯片
Approval Number
国药准字H41025555
Approval Date
Jun 19, 2020
NMPA

Glucurolactone Tablets

Product Name
葡醛内酯片
Approval Number
国药准字H41025560
Approval Date
Jun 19, 2020
NMPA

Hydrocortisone Injection

Product Name
氢化可的松注射液
Approval Number
国药准字H41024311
Approval Date
Jun 18, 2020
NMPA

Saccharated Yeast Tablets

Product Name
食母生片
Approval Number
国药准字H41025144
Approval Date
Jun 18, 2020
NMPA

宁心宝胶囊

Approval Number
国药准字Z41022412
Approval Date
Jun 18, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.